(PDF) Hubbard, N.A., Bauer, C.C.C., Siless, V., Auerbach, R.P., Elam, J.S., Frosch, I.R., Henin, A., Hofmann, S.G., Hodge, M.R., Jones, R., Lenzini, P., Lo, N., Park, A.T., Pizzagalli, D.A., Vaz-DeSouza, F., Gabrieli, J.D.E., Whitfield-Gabrieli, S., Yendiki, A., Ghosh, S.S
While semaglutide only mimics the action of GLP-1, tirzepatide also stimulates the production of gastric inhibitory polypeptide (GIP) hormones
PubMed Randomized trialRetatrutide evidence2023 Triple-Hormone-Receptor Agonist Retatrutide for Obesity, A Phase 2 Trial Primary human trial source for retatrutide obesity efficacy and safety discussions
Subscribers were up 41% in Q1 2025, to 1.7 million